Who owns Hookipa Pharma Inc equity?
- Ticker: HOOK
- CUSIP Number: 43906k100
Tip: Access positions for across all investors
Analyze quarterly positions in Hookipa Pharma Inc equity with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Hookipa Pharma Inc equity stock
Who bought or sold Hookipa Pharma Inc equity this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Baker Bros. Advisors | 8.1M | $5.8M | 0% | Mar 2024 |
|
Artal Group | 5.7M | $4.0M | 0% | Mar 2024 |
|
Knoll Capital Management | 5.5M | $3.9M | 0% | Mar 2024 |
|
EcoR1 Capital | 4.6M | $3.3M | 0% | Mar 2024 |
|
FMR | 3.4M | $2.4M | 0% | Mar 2024 |
|
Vanguard Group | 2.1M | $1.5M | 0% | Mar 2024 |
|
Morgan Stanley | 1.2M | $883k | 93% | Mar 2024 |
|
Redmile Group | 1.1M | $757k | 0% | Mar 2024 |
|
Acadian Asset Management | 882k | $627k | 106% | Mar 2024 |
|
Geode Capital Management | 665k | $473k | 25% | Mar 2024 |
|
Ikarian Capital | 531k | $378k | 0% | Mar 2024 |
|
BlackRock | 289k | $206k | -2% | Mar 2024 |
|
Susquehanna International | 259k | $184k | 100% | Mar 2024 |
|
Royal Bank of Canada | 210k | $150k | -5% | Mar 2024 |
|
Northern Trust | 157k | $112k | 41% | Mar 2024 |
|
Boothbay Fund Management | 118k | $84k | 0% | Mar 2024 |
|
Two Sigma Investments | 95k | $68k | 492% | Mar 2024 |
|
Bridgeway Capital Management | 88k | $62k | 0% | Mar 2024 |
|
Citadel Advisors | 69k | $49k | 100% | Mar 2024 |
|
XTX Topco | 61k | $44k | -62% | Mar 2024 |
|
ADAR1 Capital Management | 50k | $36k | 100% | Mar 2024 |
|
Tyler-Stone Wealth Management | 47k | $34k | 21% | Mar 2024 |
|
Virtu Financial | 43k | $31k | 100% | Mar 2024 |
|
Millennium Management | 41k | $29k | -29% | Mar 2024 |
|
Charles Schwab Investment Management | 36k | $26k | 0% | Mar 2024 |
|
Two Sigma Advisers | 36k | $25k | 100% | Mar 2024 |
|
Hrt Financial | 35k | $24k | 100% | Mar 2024 |
|
DLK Investment Management | 32k | $23k | 0% | Mar 2024 |
|
Jane Street | 26k | $19k | 100% | Mar 2024 |
|
Beacon Pointe Advisors | 23k | $19k | -6% | Dec 2023 |
|
Apella Capital | 20k | $17k | 0% | Mar 2024 |
|
Group One Trading | 17k | $12k | -67% | Mar 2024 |
|
International Assets Investment Management | 14k | $10k | 0% | Mar 2024 |
|
UBS Group | 12k | $8.9k | 112% | Mar 2024 |
|
Tower Research Capital | 11k | $7.4k | -27% | Mar 2024 |
|
Bank of America Corporation | 6.4k | $6.4k | -1% | Mar 2024 |
|
Nbc Securities | 6.0k | $4.0k | -37% | Mar 2024 |
|
Advisor Group Holdings | 4.0k | $2.8k | 0% | Mar 2024 |
|
Wells Fargo & Company | 548.00 | $390.011600 | 1% | Mar 2024 |
|
Bnp Paribas Arbitrage, Snc | 337.00 | $240.011400 | 0% | Mar 2024 |
|
Federation des caisses Desjardins du Quebec | 330.00 | $234.993000 | 100% | Mar 2024 |
|
Northwestern Mutual Wealth Management Company | 100.00 | $71.000000 | 100% | Mar 2024 |
|
Citigroup | 74.00 | $52.998800 | 0% | Mar 2024 |
|
Jpmorgan Chase & Co | 14.00 | $10.000200 | 0% | Mar 2024 |
|
Who sold out of Hookipa Pharma Inc equity?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Armistice Capital | Sep 2023 | 3.7M | $2.3M |
Two Sigma Securities | Dec 2023 | 82k | $67k |
Federated Investors | Sep 2023 | 708.00 | $435.986400 |